Literature DB >> 19679565

The DNA methylome of pediatric acute lymphoblastic leukemia.

Josef Davidsson1, Henrik Lilljebjörn, Anna Andersson, Srinivas Veerla, Jesper Heldrup, Mikael Behrendtz, Thoas Fioretos, Bertil Johansson.   

Abstract

Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy, with high hyperdiploidy [51-67 chromosomes] and the t(12;21)(p13;q22) [ETV6/RUNX1 fusion] representing the most frequent abnormalities. Although these arise in utero, there is long latency before overt ALL, showing that additional changes are needed. Gene dysregulation through hypermethylation may be such an event; however, this has not previously been investigated in a detailed fashion. We performed genome-wide methylation profiling using bacterial artificial chromosome arrays and promoter-specific analyses of high hyperdiploid and ETV6/RUNX1-positive ALLs. In addition, global gene expression analyses were performed to identify associated expression patterns. Unsupervised cluster and principal component analyses of the chromosome-wide methylome profiles could successfully subgroup the two genetic ALL types. Analysis of all currently known promoter-specific CpG islands demonstrated that several B-cell- and neoplasia-associated genes were hypermethylated and underexpressed, indicating that aberrant methylation plays a significant leukemogenic role. Interestingly, methylation hotspots were associated with chromosome bands predicted to harbor imprinted genes and the tri-/tetrasomic chromosomes in the high hyperdiploid ALLs were less methylated than their disomic counterparts. Decreased methylation of gained chromosomes is a previously unknown phenomenon that may have ramifications not only for the pathogenesis of high hyperdiploid ALL but also for other disorders with acquired or constitutional numerical chromosome anomalies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19679565     DOI: 10.1093/hmg/ddp354

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  39 in total

Review 1.  Mechanisms of epigenetic deregulation in lymphoid neoplasms.

Authors:  Yanwen Jiang; Katerina Hatzi; Rita Shaknovich
Journal:  Blood       Date:  2013-05-23       Impact factor: 22.113

2.  EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia.

Authors:  Vivien Schäfer; Jana Ernst; Jenny Rinke; Nils Winkelmann; James F Beck; Andreas Hochhaus; Bernd Gruhn; Thomas Ernst
Journal:  J Cancer Res Clin Oncol       Date:  2016-05-11       Impact factor: 4.553

3.  Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma.

Authors:  Sarah Leonard; Wenbin Wei; Jennifer Anderton; Martina Vockerodt; Martin Rowe; Paul G Murray; Ciaran B Woodman
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

4.  Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies.

Authors:  Laura E Hogan; Julia A Meyer; Jun Yang; Jinhua Wang; Nicholas Wong; Wenjian Yang; Gregory Condos; Stephen P Hunger; Elizabeth Raetz; Richard Saffery; Mary V Relling; Deepa Bhojwani; Debra J Morrison; William L Carroll
Journal:  Blood       Date:  2011-09-14       Impact factor: 22.113

Review 5.  Toxicogenomic profiling of chemically exposed humans in risk assessment.

Authors:  Cliona M McHale; Luoping Zhang; Alan E Hubbard; Martyn T Smith
Journal:  Mutat Res       Date:  2010-04-09       Impact factor: 2.433

6.  Methylation and expression analyses of Pallister-Killian syndrome reveal partial dosage compensation of tetrasomy 12p and hypomethylation of gene-poor regions on 12p.

Authors:  Josef Davidsson; Bertil Johansson
Journal:  Epigenetics       Date:  2016-02-18       Impact factor: 4.528

7.  History of Parvovirus B19 infection is associated with a DNA methylation signature in childhood acute lymphoblastic leukemia.

Authors:  Gisele M Vasconcelos; Brock C Christensen; E Andrés Houseman; Jianqiao Xiao; Carmen J Marsit; John K Wiencke; Shichun Zheng; Margaret R Karagas; Heather H Nelson; Margaret R Wrensch; Karl T Kelsey; Maria S Pombo-de-Oliveira; Joseph L Wiemels
Journal:  Epigenetics       Date:  2011-12       Impact factor: 4.528

8.  Epigenetic deregulation in pediatric acute lymphoblastic leukemia.

Authors:  Zac Chatterton; Leah Morenos; Francoise Mechinaud; David M Ashley; Jeffrey M Craig; Alexandra Sexton-Oates; Minhee S Halemba; Mandy Parkinson-Bates; Jane Ng; Debra Morrison; William L Carroll; Richard Saffery; Nicholas C Wong
Journal:  Epigenetics       Date:  2014-01-06       Impact factor: 4.528

9.  Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia.

Authors:  Huimin Geng; Sarah Brennan; Thomas A Milne; Wei-Yi Chen; Yushan Li; Christian Hurtz; Soo-Mi Kweon; Lynette Zickl; Seyedmehdi Shojaee; Donna Neuberg; Chuanxin Huang; Debabrata Biswas; Yuan Xin; Janis Racevskis; Rhett P Ketterling; Selina M Luger; Hillard Lazarus; Martin S Tallman; Jacob M Rowe; Mark R Litzow; Monica L Guzman; C David Allis; Robert G Roeder; Markus Müschen; Elisabeth Paietta; Olivier Elemento; Ari M Melnick
Journal:  Cancer Discov       Date:  2012-10-29       Impact factor: 39.397

10.  Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia.

Authors:  Maria E Figueroa; Shann-Ching Chen; Anna K Andersson; Letha A Phillips; Yushan Li; Jason Sotzen; Mondira Kundu; James R Downing; Ari Melnick; Charles G Mullighan
Journal:  J Clin Invest       Date:  2013-06-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.